Fifteen trends to expect in 2006

January 01, 2006


IFLR chooses the regulatory, legislative and transactional trends to watch out for over the coming 12 months. By Ben Maiden, Siew-Fong Leung, Daniel Andrews and James Rice

Japanese poison pills. Hedge fund-led LBOs. The first rulebook for US securitization deals. New faces at the SEC.

All of these things will occupy lawyers' time in 2006.

In both Europe and the US, 2006 will be a year of putting reforms into practice in capital markets deals as Reg AB and securities offerings reforms in the US, while Europe learns how the Markets in Financial Instruments Directive (Mifid) and the Transparency Directive will be implemented. After almost half a decade of reforms, much of 2006 will be about putting the new ways of offering securities and complying with legal requirements into effect. This should be a year of innovation, giving the most progressive advisers the opportunity to develop new deal structures and tools that take the best of the new global legal infrastructure while working around the impracticalities. Many US issuers will be looking to take advantage of simplified...



It’s not as simple as waving a cheque for HK$1 million and saying: ‘I want some shares’

Teresa Ma, of Linklaters, on retail investor restrictions for Rusal's listing

Web seminars

US and EU hybrid capital
February 3 2010
The future of hybrids, in a popular discussion between IFLR, Morrison & Foerster and Calyon

Latest Issue

March 2010

Basel III: The revenge of Basel
New Basel rules are affecting everyone differently. In the UK banks are worried about grandfathering, in Germany the headache is hybrids and in the US it's risk structures. Meanwhile Japan has some tips and Hong Kong structured its first hybrid [more]